colorectal cancer

Tumor Location an Influencer of Survival in Patients With Colorectal Cancer

06/04/2016

JCP Editors

The physical location of a primary tumor may be an indicator of survivor in patients with metastatic colorectal cancer (mCRC), according to results from a large retrospective study presented at the American Society...

The...

06/04/2016

Journal of Clinical Pathways

Research in Review

Biomarkers Predict Cetuximab Performance in Metastatic Colorectal Cancer

05/17/2016

JCP Editors

Treatment with cetuximab is most effective for patients with KRAS wild-type colorectal cancers carrying a specific genetic marker, according to a recent study. In an article published in Clinical Cancer Research,...

...

05/17/2016

Journal of Clinical Pathways

Research in Review

Breast Cancer Drug Shows Benefit in HER2-Positive Colorectal Cancer

05/05/2016

JCP Editors

Patients with human epidermal growth factor receptor 2 (HER2)-positive metastatic colorectal cancer may benefit from a targeted therapy regimen used to treat HER2-positive breast cancer with no need for added...

...

05/05/2016

Journal of Clinical Pathways

Oncology Nurse Navigators Improve GI Cancer Outcomes

04/28/2016

JCP Editors

At the second annual Oncology Nurse Advisor Navigation Summit (April 7-9, 2016; Orlando, FL), Teresa Labovich, MSN, RN, OCN, Penrose Cancer Center (Colorado Springs, CO), described a method by which gastrointestinal...

At the...

04/28/2016

Journal of Clinical Pathways

Research in Review

Multiple-Treatment Regimens for Colorectal Cancer Have High Costs and Little Benefit to Elderly Patients

03/02/2016

JCP Editors

A 10-year study has found that the rate of elderly patients receiving 3 or more treatments for metastatic colorectal cancer has increased substantially from 2000 to 2009, but that added agents may not lead to...

A...

03/02/2016

Journal of Clinical Pathways

Research in Review

Predictive Biomarker for Panitumumab Therapy Effectiveness in Patients With Colorectal Cancer

02/12/2016

JCP Editors

Expression of epidermal growth factor receptor ligands epiregulin (EREG) and amphiregulin (AREG) may help determine which patients with colorectal cancer are the most likely to benefit from panitumumab therapy. The...

...

02/12/2016

Journal of Clinical Pathways

Clinical Insights

SIRFLOX Data Show Mixed Results for Survival

08/05/2015

By Marianne Kirby Rhodes

The landmark SIRFLOX trial, a randomized controlled trial of SIR-Spheres Y90 microspheres (Sirtex) in patients with metastatic colorectal cancer (mCRC), has shown evidence suggesting that a first-line treatment strategy of standard of care...

The landmark SIRFLOX trial, a...

08/05/2015

IO Learning

News

New SIRFLOX Study Data Presented at World Congress of Gastrointestinal Cancer

08/03/2015

Adding SIR-Spheres® Y-90 resin microspheres to first-line chemotherapy for patients with unresectable metastatic colorectal cancer in the liver (mCRC) further extends Progression-Free Survival in that organBarcelona, Spain (4 July...

Adding SIR-Spheres® Y-90 resin...

08/03/2015

IO Learning

Clinical Insights

Andor van den Hoven, MD, Describes a Particle-Fluid Dynamics Study for Radioembolization of Colorectal Liver Metastases

07/28/2015

Interview by Jennifer Ford

IO360: Please describe your facility, the makeup of the IO team, and the IO procedures done at your facility.van den Hoven: I am an MD working as a PhD candidate at the Department of Radiology and Nuclear Medicine of the University Medical...

IO360: Please describe your...

07/28/2015

IO Learning

Clinical Insights

Management of Locoregional Recurrence of Rectal Cancer After Surgery Using Radiofrequency Ablation

07/17/2015

Shivank S. Bhatia, MD¹; Keith Pereira, MD¹; Seth Spector, MD²From the ¹Department of Interventional Radiology and ²Department of Surgery, Miami Veterans Affairs Healthcare System, Miami, Florida.

Shivank S. Bhatia, MD1; Keith Pereira...

Abstract: The primary mode of treatment for rectal carcinoma is resection. Despite radical surgery, 10% to 25% of patients develop local recurrence, the majority of which involve pelvic sidewall or surrounding organs. Radiofrequency ablation...

Abstract: The primary mode of...

07/17/2015

IO Learning